Phase III-Ready Non-Opoid Pain Reliever for Severe Pain

Phase III-Ready Non-Opioid Pain Reliever for Severe Pain

We are pleased to offer an innovative new formulation of cannabis for the treatment of severe cancer pain.

Developed by MedLab in Australia, NanaBis is a sophisticated blend of CBD and THC.

Clinical data already demonstrate significant pain relief in severe cancer patients.

Importantly, NanaBis is demonstrated to reduce opioid usage in these difficult-to-treat cases of cancer pain.

Prospective partners that advance into confidentiality will be provided access to extensive Preclinical and Phase II data.

Licensing partners will find a robust data package. Importantly, it may be possible to immediately enter into Phase III pivotal studies.

For further information on this interesting licensing opportunity, contact us by using the form below: